유방 재건 기술 회사, $5M 자금 조달 및 안구 상용화 마무리

게시 날짜:

리서치 트라이앵글 파크 – 생물미학, which provides a nipple-areolar complex graft for patients undergoing breast reconstruction, is stepping up plans to commercialize its lead product after having closed on $5 million in financing.

“We are very pleased to have had such interest in our Series A, allowing us to close it on Dec. 30, which will help us further accelerate the NACgraft commercialization,” said Nicholas Pashos, founder and CEO of BioAesthetics, in a statement. “On behalf of our Series A co-lead and Director Dr. Sandra Coufal, and the whole BioAesthetics team, we are thrilled with FemHealth co-leading this round and enthusiastically welcome their Managing Partner Maneesha Ghiya to our Board of Directors.”

The company had originally sought $2.5 million. It has received funding support from the North Carolina Biotechnology Center and The Launch Place.

Last fall, BioAesthetics said it had raised roughly $4.5 million, according to a securities filing. Thirty-seven investors contributed to the round, which kicked off on Sept. 9. The Triangle company is still seeking to raise another $1.7 million.

BioAesthetics was founded in 2015 as a Tulane University spin-out with the mission to improve reconstruction options for breast cancer patients after they undergo mastectomies, according to Crunchbase. It is now headquartered in RTP.

BioAesthetics의 초기 제품은 조직 공학적 유두-유륜 복합체(NAC)입니다. 이 제품은 기성품인 무세포 NAC 이식편으로 성형 및 재건 외과의사에게 제공될 예정입니다.

유방 재건 단계에서 유방절제술 후 외과 의사는 환자의 재건된 유방에 NAC 이식편을 이식합니다.

그러면 환자의 신체는 이 NAC 이식편을 건물 프레임으로 사용하여 자신의 NAC를 재생하게 됩니다. 이 특허 출원 중인 제품은 현재 전임상 단계에 있습니다.

The company in December said it was “validating its clinical manufacturing process” and that a “collaborative clinical study at Stanford Medicine” was expected to begin early this year.

“The clinical study will follow, over a 12-month period, 15 patients who receive nipple reconstruction with the NACgraft and previously underwent autologous breast reconstruction as part of treatment for breast cancer,” BioAethetics said. “The primary goal of the study is to evaluate healing time, with the secondary objectives of assessing patients’ satisfaction, well-being, self-esteem, body image, psychological well-being, nipple dimensions, and sensitivity.”

원본 기사 출처: WRAL TechWire